Additional interferon alpha for lamivudine resistant hepatitis B infection after liver transplantation: A preliminary report

Transplantation

Volumn 69, Issue 8, 2000, Pages 1739-1742

  Seehofer, Daniel ^a,b   Rayes, Nada ^a   Berg, Thomas ^a   Neuhaus, Ruth ^a   Hopf, Uwe ^a   Müller, Andrea R ^a   Bechstein, Wolf Otto ^a   Neuhaus, Peter ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ASPARTATE AMINOTRANSFERASE; LAMIVUDINE;

ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; DRUG RESPONSE; GRAFT REJECTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; REINFECTION;

EID: 0034720069     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200004270-00039     Document Type: Article

References (10)

1. Orthotopic liver transplantation for patients with hepatitis B virus related liver disease
2. Identification and characterization of mutations in Hepatitis B virus resistant to lamivudine
3. Potential mechanisms for sustained antiretroviral efficacy of AZT-3TC combination therapy
4. Drug therapy for chronic hepatitis B: Antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy
5. Combination alpha-interferon and lamivudine therapy for alpha-interferon-resistant chronic hepatitis B infection: Results of s pilot study
6. In vitro evaluation of combination therapies against hepatitis B virus replication
7. Failure of interferon to prevent recurrent hepatitis B infection in hepatic allograft
8. Follow up of recurrent hepatitis B and delta infection in liver allograft recipients after treatment with recombinant interferon-α
9. Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective
10. Synergistic inhibition of hepadnaviral replication by lamivudine in combination with penciclovir in vitro